Dipeptidyl peptidase IV is required for endometrial carcinoma cell proliferation and tumorigenesis via the IL ‐6/ STAT3 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dipeptidyl peptidase IV is required for endometrial carcinoma cell proliferation and tumorigenesis via the IL ‐6/ STAT3 pathway

Published:2021-05-09 Issue:7 Volume:47 Page:2449-2459
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Yang Xiaoqing¹,Zhu Yi¹²,Shi Qin¹^ORCID,Zhao Xinxin¹,Huang Yan¹,Yao Feng¹,Zhang Yuquan¹,Wang Zhiwei³

Affiliation:

1. Department of Obstetrics and Gynecology Affiliated Hospital of Nantong University Nantong Jiangsu China

2. Department of Obstetrics and Gynecology Nantong Maternity and Infant Hospital Nantong Jiangsu China

3. Department of General Surgery Affiliated Hospital of Nantong University Nantong Jiangsu China

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14788

Reference30 articles.

1. Cancer statistics in China, 2015

2. Cancer statistics, 2020

3. Endometrial cancer: molecular and therapeutic aspects

4. CD26 expression is attenuated by TGF‐β and SDF‐1 autocrine signaling on stromal myofibroblasts in human breast cancers

5. Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The roles and clinical applications of interleukins in endometrial carcinoma;Frontiers in Oncology;2022-11-30

2. Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer;Frontiers in Molecular Biosciences;2022-07-01

3. miR-486-3p Controls the Apoptosis of Endometrial Carcinoma Cells;Journal of Biomaterials and Tissue Engineering;2022-05-01

4. DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells;Frontiers in Oncology;2021-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3